International Society for NeuroVirology

Agenda

The primary goal of the 20th International Symposium on NeuroVirology and 2025 Conference on HIV in the Central Nervous System is to bring together scientists and clinicians with interests in neurovirology and related fields, and to provide a venue that promotes collaboration and communication of findings in these fields.

The list of plenary speakers for the Symposium is now available.

Meeting Overview

This four-day Symposium will feature presentations from leading experts in these areas of interest below.

New Technologies/Initiatives

Role of Viruses in Aging/Dementias and Psychiatric Disorders

Virus-associated Chronic Conditions

Herpesviruses and Neurological Diseases

Global Neurovirology/Re-emerging Pathogens

HIV Persistence, Therapy and Cure in the Brain

Exosomes - Biomarkers and Therapy

NeuroHIV and Co-morbidities (including DOA)

Artificial Intelligence in Science and Medicine

Multimodal Integrated Analysis and Assessment Development for NeuroHIV Outcomes (MIADD) - Brain health disorders (BHDs) affect a substantial proportion of people with HIV (PWH), including those who achieve viral suppression with antiretroviral therapy (ART). Unfortunately, there is significant heterogeneity in the clinical expression of BHDs among PWH, which hampers prevention and treatment efforts.

This symposium introduces the MIAAD-NHIV project, a multi-national collaborative effort to leverage prior and ongoing NIH-sponsored research projects to better understand the heterogeneity of BHDs in PWH on suppressive ART using data from established cohorts and advanced analytic strategies, including machine learning and inferential methods. The results have potential to identify actionable mechanisms underlying complex clinical expressions of BHDs in PWH. The session will review the conceptual underpinnings of the project, the design and analytic strategy (including potential pitfalls and alternatives), and preliminary findings.